Three new cephalosporin antibiotics, prepared by substitution of heterocyclic groups on 7-aminocephalosporanic acid, possess 
characteristics of the antibiotics were verified by successful therapy of experimental mouse infections. Regression lines were calculated to show the correlation of agardilution MIC values with zones of inhibition by the disc testing procedure. Because each of the three new cephalosporins has certain advantageous properties over cephalothin and cephaloridine, additional toxicological and pharmacological data should be obtained for all three compounds.
The clinical efficacy of parenterally administered cephalosporin antibiotics, cephalothin and cephaloridine, has been well established. However, certain problems occur during therapy with these antibiotics. For example, because of pain on intramuscular injection, cephalothin is usually administered intravenously. Cephaloridine possesses excellent antibacterial activity and has low toxicity, but is associated, rarely, with an adverse effect on renal function. New cephalosporin antibiotics, for which laboratory data have provided evidence for possible advantages over cephalothin or cephaloridine, may prove to be clinically useful compounds. Three new cephalosporin antibiotics, prepared from 7-aminocephalosporanic acid by substitution of heterocyclic groups (heterocyclic cephalosporins), do possess certain chemical and biological properties that make them candidates for clinical evaluation. One of these antibiotics, cefazolin, has been investigated extensively in Japan (10, (12) (13) (14) (15) 19) . This communication summarizes the data from a laboratory study with cefazolin and two chemically related cephalosporin antibiotics. The chemical names for the three new compounds (i, ii, iii) shown in Fig. 1 are, respectively, 3-(5-methyl-1, 3, 4-thiadiazol-2-ylthiomethyl)-7-[2-(3-sydnone) acetamido]-3-cephem-4-carboxylic acid, sodium salt; 7-Dmandelamido -3 -(1 -methyl-1H -tetrazol -5 -ylthiomethyl)-3-cephem-4-carboxylic acid, sodium salt; and 3-(5-methyl-1, 3, 4-thiadiazol-2-ylthiomethyl)-7-[2-(1H -tetrazol-1 -yl)acetamido] -3 -cephem-4-carboxylic acid, sodium salt. A generic name has not been assigned for the "mandelic-tetrazole" derivative (ii), thus, this antibiotic will be called "CMT.") ANTIMICROB. AG. CHEMOTHER. bial genus were used, each culture was si of a different strain by phage typing, sero chemical reactions, or antibiotic susceptibil Disc susceptibility testing. Strains of ba tested for susceptibility to the antibioti standardized disc technique described by tho Drug Administration (5) . This procedure i cation of the Bauer-Kirby (or Kirby-Baue ceptibility testing method (2) .
MIC detedmnations. Broth-dilution or as procedures were used to determine antibioi inhibitory concentrations (MIC) for all bacteria. For After contacts for various periods of time at 37 C, the inoculated discs were transferred to plates containing antibiotic-free agar. To insure that no residual antibiotic remained, discs were transferred via two intermediate antibiotic-free agar plates. All plates to which discs were transferred were incubated at 37 C during the entire transfer time.
An MIC was determined from the filters that remained on the original antibiotic plates for 24 hr. The MIC was the lowest level of antibiotic that inhibited visual growth of the culture. Discs with no growth were then transferred, and incubation was continued. After sufficient incubation for visible colony formation, the colonies that grew on the surface of each filter were counted. Each colony represented a surviving organism, and the number of survivors was compared with the number of bacteria used to inoculate the membrane filter. From these data, bactericidal activity of the antibiotics was determined; i.e., the minimal bactericidal concentration (MBC) was obtained from the discs that were transferred to the antibiotic-free plates at 24 hr, and was the concentration of antibiotic that killed 599.9% of the inoculated bacteria. This MBC was compared with the MIC that was determined from the same series of discs at 24 hr. In addition to the MBC, the rate of bactericidal activity could be estimated by counting colonies on discs that were transferred to antibiotic-free agar at incubation times of less than 24 hr.
Microbiological assays. Disc-plate assays with Sarcina lutea strain PCI-1001-FDA or Bacillus subtilis strain ATCC 6633 were used. The greatest sensitivity was obtained by using the B. subtilis assay with Antibiotic Medium 5 (Difco) at pH 8.0 for cephalothin, the B. subtilis assay with the agar adjusted to pH 6.0 for the heterocycic compounds, and the S. lutea assay with agar at pH 8.0 for cephaloridine.
Concentration of antibiotic in mouse blood or urine. The disc-plate assays described above were utilized to determine antibiotic concentration in mouse blood or urine. All antibiotics were administered to mice subcutaneously at equal doses of 20 mg per kg of body weight. The blood was collected from the orbital sinus in heparinized hematocrit tubes, which were allowed to fill by capillary action (23) . Paper discs (6. 35 mm, Schleicher & Schuell Co., Inc.) were saturated with blood and immediately placed on inoculated assay plates. Urine specimens were diluted in saline and assayed as soon as they were collected.
Chemical stability studies. The stability of the cephalosporin antibiotics was studied by incubating solutions of the antibiotics at 4, 25, or 37 C. Samples were withdrawn at intervals and immediately frozen with alcohol and dry ice. After all samples were collected, they were assayed by the assay procedures described above.
Metabolism of antibiotics. To assess the extent of metabolic degradation of the antibiotics, the paper chromatographic method of Hoehn and Pugh (9) Stability studies with bacterial enzymes. 3-Lactamase enzymes (penicillinase and cephalosporinase) were used to evaluate stability of the antibiotics to enzymatic degradation. The enzymes were derived from several bacterial species, including B. cereus, Staphylococcus aureus, Enterobacter sp., Proteus sp., Serratia sp., and Pseudomonas sp. Penicillinase (Riker) was the only highly purified enzyme used; enzymes from other organisms were only partially purified preparations. Activity of the enzymes against each of the five cephalosporins was measured by a previously described assay method (21, 24) .
Effect of human sera on antibacterial activity. The percentage of antibacterial activity bound by human serum was estimated by comparing serum and buffer standard curves from assays described above.
Therapy of experimental infections. The in vivo efficacy of the antibiotics was studied by therapy of experimental infections in mice. Groups of eight white mice (11 to 13 g) were treated subcutaneously at various times after intraperitoneal bacterial challenge. Antibiotics were usually administered at 1 and 5 hr post-infection; however, in some experiments, other dosage regimens were employed. Deaths and surviv- (Table 1) . In some instances, the three heterocyclic derivatives were slightly less active than cephalothin or cephaloridine.
Barber (1) and Chabbert (4) have shown that the addition of 5% NaCl to Trypticase Soy media provides conditions permitting the resistant cells within the heterogeneous population of methicillin-resistant S. aureus cultures to express their resistance. When this procedure was used, three of the five cephalosporin antibiotics shown were more active than methicillin itself against this type of S. aureus culture (Table 2) . Nevertheless, a certain amount of "multiple resistance" between methicillin and all of these cephalosporins was evident.
Against gram-negative bacteria, CMT was the most active of the heterocyclic cephalosporins, followed in order by cephanone and cefazolin ( (Table 5 ). With this latter method, the killing of E. coli became evident after 3 hr, but activity against S. aureus was somewhat delayed.
All five cephalosporin antibiotics were resistant to degradation by penicillinase derived from either B. cereus or S. aureus (Table 6) . Cephaloridine, cefazolin, and cephanone were slightly affected only by the high concentrations of the enzymes used, but cephalothin and CMT were essentially unchanged.
Antibiotic CMT was very stable to cephalosporinases derived from several gram-negative bacilli, and cephanone was more stable than cephalothin ( Table 7) . Resistance of Enterobacter sp. and indole-positive Proteus sp. to cephalothin may be due to cephalosporinase production by these bacteria. All cultures from these two genera that were tested (Table 7) Peak concentrations of cefazolin and cephanone in mouse blood exceeded those obtained with similar doses of cephalothin or cephaloridine (Table 8 ). The half-lives for cefazolin (36.2 4 3.5 min) and cephanone (29.5 i 2.2 min) were similar to that for cephaloridine (33.8 i 4.1 min). On the other hand, CMT concentrations in blood were about equal to those of cephaloridine, but the CMT half-life (20.5 ± 2.9 min) was as rapid as for cephalothin (15.8 + 4.1 
min).
Binding of antibacterial activity of the five antibiotics, as estimated by comparing standard assay curves prepared in either saline or human serum, followed several patterns ( Table 9 ). The activity of cephaloridine was essentially the same in saline or serum, indicating very little binding. Binding of CMT was not as great as with cephalothin; however, the amount of binding for both of these antibiotics did not change with concentrations. Serum binding of cefazolin and cephanone was concentration-dependent, increasing as the concentration decreased. Kind et al. (11) reported binding of cephalothin and cephaloridine as 65 and 13%, respectively, in pooled human serum, by the ultrafiltration method. Nishida et al. (13), using essentially the same method, showed a higher percentage of binding for cephalothin (79%) and cephaloridine (31 %), and reported cefazolin as 74%. The ratio of 79% to 74% for cephalothin and cefazolin by these latter investigators compares with the 53% to 48% ratio at the 5-,ug level as shown in Table 9 . However, binding of activity against different organisms can vary (8) , and may not accurately predict protein binding. Therefore, additional studies with procedures other than those employed in this experiment may be necessary to predict the degrees of binding to serum proteins.
ED50 values for subcutaneous administration of five cephalosporins in therapy of experimental infections in mice are shown in Tables 10 and 11 . To interpret properly the meaning of the two-dose ED50 values in Table 10 , the in vitro activity, concentrations in serum, excretion rates, and meta- a Enzyme potency is expressed as the greatest dilution of enzyme retaining the ability to degrade a known amount of cephalothin under the test conditions used (see Materials and Methods).
bRelative cephalosporinase stability compared with cephalothin, which was arbitrarily assigned the value of 1. Fig. 1. bolic patterns for all of the compounds must be compared.
Peak serum concentrations of cefazolin and cephanone were higher than those of cephaloridine, and the excretion rates were similar (Table  8) . Therefore, the infecting bacteria were exposed in the animal to these antibiotics for similar periods of time; ED5o values (Table 10) for these three antibiotics can be compared. Cephaloridine, cefazolin, and cephanone are metabolically stable and are excreted unchanged in urine. Both cefazolin and cephanone are less active in vitro than cephaloridine against some gram-positive cocci (Table 1) . Against gram-negative bacilli, the heterocyclic compounds have activities equal to or twice those for cephaloridine (Table 3 ). In addition, cephanone exhibits a degree of stability to 3-lactamase derived from certain gram-negative bacilli (Table 7) . When all of these facts about cefazolin and cephanone are considered, the expected ED50 values for these antibiotics would be about equal to cephaloridine against (1 and 5 hr postinfection).
S. aureus and D. pneumoniae infections, at least twice that for cephaloridine against Streptococcus pyogenes infections, and one-half to about equal to those for cephaloridine in therapy of infections caused by E. coli, K. pneumoniae, P. mirabilis, Salmonella typhosa, and Shigella flexneri. Cefazolin was not expected to be effective in treatment of infections caused by the ,-lactamase-producing P. morganii, but therapy with cephanone would be successful. The data presented in Table 10 confirmed these predictions.
On the other hand, peak serum concentrations of CMT are equal to those of cephaloridine, but the excretion rate is rapid, like that of cephalothin (Table 8) . Therefore, the infecting bacteria are in contact with cephalothin or CMT in the mouse for only short periods of time; ED50 values (Table  10) for these two antibiotics can be compared. Also, unlike cephalothin, CMT is metabolically stable. Antibiotic CMT is slightly less active than cephalothin in vitro against S. aureus or D. pneumoniae, but about equal in activity against S. pyogenes (Table 1) . Against gram-negative bacilli, CMT is from 2 to >100 times more active than cephalothin (Table 3 ). In addition, CMT is stable to j3-lactamases from gram-negative bacilli (Table   7) . When these facts about CMT were considered, the ED50 values shown in Table 10 Fig. 1 .
bNo zone surrounding the 6-mm paper disc.
for the heterocyclic cephalosporins may be interpreted to predict probable clinical efficacy. Successful therapy with cefazolin has already partially supported this prediction (19) . However, the size and frequency of dosage needed in human therapy may vary with each antibiotic. This is evident from the study ( (Tables 1-3 ) and the disc data presented in Table 12 , there may be a slight extension of the activity spectrum for cefazolin, and the spectra of CMT and cephanone can include bacterial species that produce cephalosporinase. In addition, serum concentrations attainable in humans with the heterocyclic cephalosporins may be very high (13) . Sp.
- Fig. 2, 3 The original purpose of these comparative studies with five antibiotics was to select one of the heterocyclic cephalosporin antibiotics that might warrant clinical trial. However, analysis of the data presented above makes that selection difficult. In fact, each of the three newer cephalosporins has certain advantageous characteristics. For example, all three antibiotics have excellent in vitro activity against gram-negative bacilli, peak serum concentrations of cefazolin and cephanone are very high, and the better in vitro activity and stability to cephalosporinase of CMT easily compensates for its generally lower blood levels. Thus, all three of the newer cephalosporins are promising, and additional toxicological and pharmacological data should be obtained. 
